NovaBridge Biosciences names Martin Dewhurst independent director - NBP News | RalliesNovaBridge Biosciences names Martin Dewhurst independent director
N
NBP• NovaBridge Biosciences appoints new independent director
- NovaBridge Biosciences appointed Martin Dewhurst as an independent director, effective immediately.
- Dewhurst joined the Audit Committee and also took a seat on the Compensation Committee.
- He brings more than 30 years of board and C-suite experience across biotech, biopharma, medical devices, health tech and healthcare investment.
- Independent director Liu Xin departed the board.
MDCX
•
